Field trip

Field Trip Health & Wellness Ltd. Announces Updated Time for Fiscal Second Quarter 2023 Financial Results and Conference Call

Retrieved on: 
Monday, November 28, 2022
Mental health, Human, Field trip, TSX Venture Exchange, Patient, Webcast, SEDAR, Wellness, Risk, Research, Thanksgiving, Pharmaceutical industry

The Company will conduct a conference call and webcast to discuss its results the following morning, Wednesday, November 30, 2022 at 8:30 a.m.

Key Points: 
  • The Company will conduct a conference call and webcast to discuss its results the following morning, Wednesday, November 30, 2022 at 8:30 a.m.
  • A live webcast of the conference call can be accessed via the Events and Presentations section of the Field Trip Health & Wellness Investor Relations website here .
  • To access the replay dial 1-844-512-2921 (within the U.S.) or 1-412-317-6671 (outside the U.S.) and provide conference ID 13734182.
  • The webcast will be archived and available in the Events and Presentations section of the Field Trip Health & Wellness Investor Relations website approximately one hour after the conclusion of the live call.

Field Trip Health & Wellness Ltd. Strengthens Leadership Team With Two Executive Appointments, Schedules Fiscal Second Quarter 2023 Conference Call

Retrieved on: 
Tuesday, November 22, 2022
Mental health, Public health, Addiction, Human, Partner, Alternative medicine, Corporation, SEDAR, Financial regulation, Master, University, Curriculum, Field trip, Regulatory compliance, Conference, Centre for Addiction and Mental Health, TSX Venture Exchange, Patient, Education, Medicine, CAMH, Assistant, Wellness, Pharmacology, Risk, Division, General counsel, University of New Brunswick, Toxicology, Webcast, Financial technology, Depression, Osgoode Hall Law School, Research, Bachelor of Science, TMX Group, Senior, Addiction medicine, Management, Pharmaceutical industry

TORONTO, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in the delivery of psychedelic therapies, today announced that it has strengthened its leadership team with the hiring of two senior executives.

Key Points: 
  • The Company has appointed Stacey Hoisak as Senior Vice President, General Counsel, and Dr. Monique Moller as Vice President, Integrative Health.
  • Ronan Levy, Chairman & CEO, commented, We have deepened the expertise of the Field Trip leadership team with these talented individuals as we head into this pivotal phase of our growth plans.
  • Most recently, Ms. Hoisak held the roles of Chief Executive Officer, Chief Legal Officer, Chief Privacy Officer and Director of Coinsquare Ltd.
  • A live webcast of the conference call can be accessed via the Events and Presentations section of the Field Trip Health & Wellness Investor Relations website here .

Field Trip Announces the Launch of Freedom by Field Trip™, a First-of-Its-Kind Ketamine Therapy Program

Retrieved on: 
Tuesday, November 15, 2022
Mental health, Human, Chapter Two, Field trip, Trauma, TSX Venture Exchange, Patient, Freedom, Anxiety, Alternative, SEDAR, Depression, Wellness, Risk, Chapter Three, Ketamine, Meditation, Chapter One, Pharmaceutical industry, Medicine, Washington State

This led us to launch Freedom by Field Trip, which enables us to expand beyond our physical footprint and amplify the power of our therapies with flexibility, accessibility and a truly holistic approach to healing.

Key Points: 
  • This led us to launch Freedom by Field Trip, which enables us to expand beyond our physical footprint and amplify the power of our therapies with flexibility, accessibility and a truly holistic approach to healing.
  • The Program provides up to 12 at-home or in-person ketamine exploration dosing sessions per year, medical supervision to customize the ketamine explorations and one-on-one integration therapy sessions as well as unlimited group integration sessions with licensed therapists.
  • Freedom by Field Trip redefines how we think about treating depression, anxiety, trauma and other mental health conditions.
  • Freedom by Field Trip will initially be available in California and Washington State and the Company expects to rollout to additional jurisdictions in 2023.

Field Trip Health & Wellness Releases Letter to Shareholders

Retrieved on: 
Tuesday, November 1, 2022
DMT, CEO, Field trip, SEDAR, News, LSD, Toronto Stock Exchange, Research, Consciousness, Industry, GLOBE, Task force, LOT, Wellness, 1983 Oregon State vs. Oregon football game, White House, TSX Venture Exchange, TSX, Computershare, Human, National University of Natural Medicine, Trip, Phrase, University, Education, Private Securities Litigation Reform Act, Mescaline, Company, Psilocybin, FDA, Risk, Patient, Music, White, Drug development, Letter, Canadian Securities Exchange, Mental health, MDMA, Management, Pharmaceutical industry, Security (finance), Nightclub, Taxicab

TORONTO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or Field Trip), a global leader in the development and delivery of psychedelic therapies, today released the following letter to shareholders from the Companys Chairman & Chief Executive Officer, Ronan Levy, and President, Mujeeb Jafferi.

Key Points: 
  • TORONTO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or Field Trip), a global leader in the development and delivery of psychedelic therapies, today released the following letter to shareholders from the Companys Chairman & Chief Executive Officer, Ronan Levy, and President, Mujeeb Jafferi.
  • Let us begin by reviewing the path that led to Field Trip Health & Wellness Ltd. (FTHW) becoming a stand-alone entity on the TSX Venture Exchange (TSX-V).
  • In October 2020, Field Trip Health Ltd. (FTRP), which was a predecessor to FTHW, listed on the Canadian Securities Exchange by means of a reverse-takeover.
  • FTRP was born with two operating divisions: (1) Field Trip Discovery, which operated its drug development efforts advancing the molecule now known as RE-104, Isoprocin Gluturate; and (2) Field Trip Health, which operated its world-class clinical infrastructure and digital technologies business.

Field Trip Health & Wellness to Participate in Upcoming November Conferences

Retrieved on: 
Monday, October 31, 2022
Phrase, SEDAR, Private Securities Litigation Reform Act, CEO, Chief executive officer, Wellness, Human, Company, TSX Venture Exchange, Risk, Field trip, Management, Public relations

Format: Company Presentation with Ronan Levy, Chairman & CEO, Field Trip Health & Wellness

Key Points: 
  • Format: Company Presentation with Ronan Levy, Chairman & CEO, Field Trip Health & Wellness
    Format: Panel Presentation with Ronan Levy, Chairman & CEO, Field Trip Health & Wellness, The Future of Psychedelics: Entrepreneurial Perspectives
    Field Trips management team will also hold one-on-one investor meetings throughout the duration of the conferences.
  • Institutional investors interested in scheduling a meeting, please contact KCSA Strategic Communications at [email protected] .
  • About Field Trip Health & Wellness Ltd.
    With a large global community of psychedelic-interested people, proprietary psychedelic therapies generating transformative results for people in the treatment of mental health conditions and a brand and share of voice that is reaching millions of people, Field Trip is a center of gravity for the psychedelic renaissance.
  • Although the management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect.

Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs

Retrieved on: 
Monday, October 24, 2022
CFO, LAVA, Deloitte, NASDAQ, Depression, Publication, Corporation, Benitec Biopharma, University, Medicine, University of Lynchburg, CEO, Phrase, Physician assistant, LLP, Professional practice of behavior analysis, Therapy, Toronto Stock Exchange, Reunion, Neuroscience, Professional Psychology: Research and Practice, Cancer, Private Securities Litigation Reform Act, Pharmacia, Yale school, Distinguished Fellow of the British Computer Society, Medical Affairs Bureau, Company, Industry, Certified Public Accountant, Yale School of Medicine, American Academy, GLOBE, EDGAR, Assistant, Risk, Time, TSX, Field trip, Mental health, Aviva, Board, University of Hartford, Salix Pharmaceuticals, Inflammation, AstraZeneca, Hartford, Connecticut, Patient, Acquisition, Financial management, Research, SEDAR, Pharmaceutical industry

TORONTO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) ("Reunion" or the Company), a biopharmaceutical company committed to developing innovative therapeutic solutions for underserved mental health conditions, announced today that it has appointed Edward Smith as the Companys Chief Financial Officer and Aviva Asnis-Alibozek as Vice President, Medical Affairs, effective immediately.

Key Points: 
  • TORONTO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) ("Reunion" or the Company), a biopharmaceutical company committed to developing innovative therapeutic solutions for underserved mental health conditions, announced today that it has appointed Edward Smith as the Companys Chief Financial Officer and Aviva Asnis-Alibozek as Vice President, Medical Affairs, effective immediately.
  • Dr. Asnis-Alibozek earned her Doctor of Medical Science degree in the advanced professional practice of administrative medicine from the University of Lynchburg.
  • Edward Smith succeeds Donna Wong who has resigned as Chief Financial Officer.
  • To be added to the Reunion Neuroscience email list, please email [email protected] with REUN in the subject line.

Field Trip Announces Relaunch and Refresh of Its Award-Winning Psychedelic App

Retrieved on: 
Thursday, October 13, 2022
App Store (iOS/iPadOS), Field trip, Education, Twitter, Instagram, Music, Google Play, Human, Company, TSX Venture Exchange, Â, CEO, Phrase, GLOBE, Wellness, App store, Joe Thomas (actor), Risk, Consciousness, SEDAR, Satellite navigation device, Nightclub, Pharmaceutical industry

In addition, Field Trip will soon include six exclusive tracks from Wavepaths, the global leader in music solutions for psychedelic therapy.

Key Points: 
  • In addition, Field Trip will soon include six exclusive tracks from Wavepaths, the global leader in music solutions for psychedelic therapy.
  • We are incredibly excited to release the Field Trip app, said Mujeeb Jafferi, Field Trips President.
  • Our strategy now is to engage as many people as possible in conversations around these powerful compounds and experiences, with the Field Trip app as the focal point for that strategy, supported by our Field Trip locations around the world.
  • These will include new and innovative therapeutic programs utilizing legal psychedelic compounds and non-ordinary states of consciousness, and an accelerated development program for the Field Trip app.

Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives on Psychedelics Conference

Retrieved on: 
Wednesday, October 12, 2022
PBC, Therapy, TSX, Science, New York Academy of Medicine, Attention, Toronto Stock Exchange, Field trip, NASDAQ, Horizon, Reunion, Neuroscience, Depression, Mental health, Capital, Private Securities Litigation Reform Act, Company, Industry, CEO, CNS, Phrase, GLOBE, EDGAR, Risk, SEDAR, Pharmaceutical industry, Nightclub

The panel will take place on Thursday, Oct. 13, 2022, at 2:30 p.m.

Key Points: 
  • The panel will take place on Thursday, Oct. 13, 2022, at 2:30 p.m.
  • As such, it is vital that we think about psychedelics as an important component to mental health treatment in much the same way that we evaluate the use of traditional therapeutics.
  • Presented by Horizons PBC, a public benefit corporation, the Perspectives on Psychedelics conference is the largest and longest-running annual gathering of the psychedelic community in the world.
  • To be added to the Reunion Neuroscience email list, please email [email protected] with REUN in the subject line.

Reunion Neuroscience Inc. Announces Executive Changes

Retrieved on: 
Friday, October 7, 2022
TSX, Toronto Stock Exchange, Field trip, NASDAQ, General counsel, Reunion, Neuroscience, Depression, Corporation, Private Securities Litigation Reform Act, Company, Phrase, GLOBE, EDGAR, Risk, SEDAR, Pharmaceutical industry

TORONTO, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc .

Key Points: 
  • TORONTO, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc .
  • Additionally, the Company has appointed Greg Mayes, President and Chief Executive Officer, Reunion, as Director and Donna Wong, Chief Financial Officer, Reunion, as Corporate Secretary, effective October 7, 2022.
  • Reunion is a leader in novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds.
  • To be added to the Reunion Neuroscience email list, please email [email protected] with REUN in the subject line.

Field Trip Health & Wellness to Participate in the Cantor Fitzgerald Symposium on Mental Health Clinics on October 11th

Retrieved on: 
Tuesday, October 4, 2022
GLOBE, Phrase, TSX Venture Exchange, Private Securities Litigation Reform Act, Wellness, Twitter, Instagram, SEDAR, Risk, Field trip, Cantor, Company, Risk management, Public relations

TORONTO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or Field Trip), a global leader in psychedelic therapies, today announced it will participate in a virtual fireside chat at Cantor Fitzgeralds Symposium on Mental Health Clinics, taking place on Tuesday, October 11, 2022.

Key Points: 
  • TORONTO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or Field Trip), a global leader in psychedelic therapies, today announced it will participate in a virtual fireside chat at Cantor Fitzgeralds Symposium on Mental Health Clinics, taking place on Tuesday, October 11, 2022.
  • Mujeeb Jafferi, President of Field Trip, will present at the virtual fireside chat at 8:00 a.m. Eastern Time on Tuesday, October 11, 2022.
  • Institutional investors interested in scheduling a meeting with Field Trips management team, please contact KCSA Strategic Communications at [email protected] .
  • About Field Trip Health & Wellness Ltd.
    Field Trip Health & Wellness Ltd. is a global leader in psychedelic therapies.